Showing 1 - 3 results of 3 for search 'Liqing Kang', query time: 0.01s Refine Results
  1. 1
    BCMA CAR-T therapy as salvage therapy in patients with plasmablastic myeloma

    BCMA CAR-T therapy as salvage therapy in patients with plasmablastic myeloma by Chengwei Jin, Jing Deng, Ying Jiang, Jun Zhu, Liqing Kang, Su Li

    Published 2025-12-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    BCMA CAR-T therapy combined with pomalidomide is a safe and effective treatment for relapsed/refractory multiple myeloma

    BCMA CAR-T therapy combined with pomalidomide is a safe and effective treatment for relapsed/refractory multiple myeloma by Yuhan Yan, Yixuan Tu, Qian Cheng, Jian Zhang, Erhua Wang, Zuqun Deng, Yan Yu, Liwen Wang, Rui Liu, Ling Chu, Liqing Kang, Jing Liu, Xin Li

    Published 2024-11-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    PD-1 downregulation enhances CAR-T cell antitumor efficiency by preserving a cell memory phenotype and reducing exhaustion

    PD-1 downregulation enhances CAR-T cell antitumor efficiency by preserving a cell memory phenotype and reducing exhaustion by Lei Yu, Yan Wang, Jin Wang, Zhiqiang Liu, Feng Liu, Han Zhao, Yi Tao, Jian-Qing Mi, Nan Xu, Wanyan Ouyang, Shi-Wei Jin, Wei-Yang Liu, Liuqingqing Zhang, Liqing Kang, Yuanfang Liu

    Published 2024-04-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: